Lentiviral gene transfer therapy for XSCID
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lentiviral gene transfer therapy for XSCID, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) [Phase 1, Phase 2]